on 21 Oct 2022
Last Applicant/ Owned by
invIOs GmbH
Campus-Vienna-Biocenter 5
Wien, , 1030
Serial Number
UK00003841594 filed on 21st Oct 2022
Registration Number
UK00003841594 registered on
16th Jun 2023
Correspondent Address
1 St Augustine's Place
Bristol,
BS1 4UD
Chemical, biological and biochemical products and reagents for the cultivation of human immune cells, in particular T-cells, for medical purposes in the treatment of immuno-oncological diseases.
Human immune cells, in particular T-cells, for medical or clinical purposes; human immune cells, in particular T-cells, for scientific and medical research; biological and pharmaceutical compositions containing human immune cells, in particular T-cells; biological and pharmaceutical preparations for use in medical and clinical cell therapy, in particular immune cell therapy, in particular T-cell therapy; Biological and pharmaceutical composition containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological and pharmaceutical preparations containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological and pharmaceutical preparations in the form of living cells for use in the treatment of immuno-oncological diseases.
Development of biological and pharmaceutical medicinal products for the treatment of diseases using a cell therapy platform; contract manufacturing of therapeutic medicinal products, namely contract manufacturing of cell therapies for the treatment of inflammatory diseases, diseases of the immune system and cancer; Contract manufacturing for others, in particular manufacturing of pharmaceutical preparations for health care, for the treatment of people suffering from diseases treated by cell therapy or regenerative medicine products, namely medicinal products for human use including investigational medicinal products, investigational biological products, cell therapy preparations and advanced therapy medicinal products; all the foregoing not in connection with medical diagnostics, and cancer profiling.
Medical services related to the treatment and processing of human cells; medical services, namely immune cell therapy; medical services, namely immune cell modification; medical services, namely administration of immune cells; medical consulting related to immune cell therapy; all of the foregoing not in connection with medical diagnostics, and cancer profiling.
UK00003841594
Word
Individual